symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
PTIX,0.86,0.176633,13468,3724626,0,0.726-2.74,0.01,"Protagenic Therapeutics, Inc.",USD,0001022899,US74365N1037,74365N103,NASDAQ Capital Market,NASDAQ,Biotechnology,https://www.protagenic.com,"Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound is PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company is based in New York, New York.",Dr. Garo H. Armen Ph.D.,Healthcare,US,,212 994 8200,149 Fifth Avenue,New York,NY,10010,,1.0954,https://financialmodelingprep.com/image-stock/PTIX.png,2021-04-27,False,False,True,False,False
